{"id":"https://openalex.org/W2003648327","doi":"https://doi.org/10.1016/j.bmcl.2013.08.007","title":"Design, synthesis and biological evaluation of peptide derivatives of l-dopa as anti-parkinsonian agents","display_name":"Design, synthesis and biological evaluation of peptide derivatives of l-dopa as anti-parkinsonian agents","publication_year":2013,"publication_date":"2013-08-11","ids":{"openalex":"https://openalex.org/W2003648327","doi":"https://doi.org/10.1016/j.bmcl.2013.08.007","mag":"2003648327","pmid":"https://pubmed.ncbi.nlm.nih.gov/23973169"},"language":"en","primary_location":{"id":"doi:10.1016/j.bmcl.2013.08.007","doi":"https://doi.org/10.1016/j.bmcl.2013.08.007","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2013.08.007","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085359308","display_name":"Tao Zhou","orcid":"https://orcid.org/0000-0003-4510-3639","observed_orcids":["https://orcid.org/0000-0003-4510-3639","https://orcid.org/0000-0002-8145-712X","https://orcid.org/0009-0008-2894-7470"]},"institutions":[{"id":"https://openalex.org/I75059550","display_name":"Zhejiang Gongshang University","ror":"https://ror.org/0569mkk41","country_code":"CN","type":"education","lineage":["https://openalex.org/I75059550"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Tao Zhou","raw_affiliation_strings":["School of Food Science and Biotechnology, Zhejiang Gongshang University, Hangzhou, Zhejiang 310035, PR China. taozhou@zjgsu.edu.cn","School of Food Science and Biotechnology, Zhejiang Gongshang University, Hangzhou, Zhejiang 310035, PR China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Food Science and Biotechnology, Zhejiang Gongshang University, Hangzhou, Zhejiang 310035, PR China. taozhou@zjgsu.edu.cn","institution_ids":["https://openalex.org/I75059550"]},{"raw_affiliation_string":"School of Food Science and Biotechnology, Zhejiang Gongshang University, Hangzhou, Zhejiang 310035, PR China","institution_ids":["https://openalex.org/I75059550"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020843793","display_name":"Robert C. Hider","orcid":"https://orcid.org/0000-0003-1330-5797","observed_orcids":["https://orcid.org/0000-0003-1330-5797"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Robert C. Hider","raw_affiliation_strings":["Division of Pharmaceutical Science, King\u2019s College London, Franklin-Wilkins Building, 150 Stamford Street, London SE1 9NH, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmaceutical Science, King\u2019s College London, Franklin-Wilkins Building, 150 Stamford Street, London SE1 9NH, UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105511214","display_name":"Peter G. Jenner","orcid":"https://orcid.org/0009-0006-0327-7584","observed_orcids":["https://orcid.org/0009-0006-0327-7584"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Peter Jenner","raw_affiliation_strings":["NDRC, School of Biomedical and Health Sciences, King\u2019s College, London SE1 1UL, UK","Proximagen Neuroscience plc, Hodgkin Building, King\u2019s College, London SE1 1UL, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NDRC, School of Biomedical and Health Sciences, King\u2019s College, London SE1 1UL, UK","institution_ids":["https://openalex.org/I183935753"]},{"raw_affiliation_string":"Proximagen Neuroscience plc, Hodgkin Building, King\u2019s College, London SE1 1UL, UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Bruce Campbell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Bruce Campbell","raw_affiliation_strings":["Proximagen Neuroscience plc, Hodgkin Building, King\u2019s College, London SE1 1UL, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Proximagen Neuroscience plc, Hodgkin Building, King\u2019s College, London SE1 1UL, UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Christopher J. Hobbs","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Christopher J. Hobbs","raw_affiliation_strings":["Proximagen Neuroscience plc, Hodgkin Building, King\u2019s College, London SE1 1UL, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Proximagen Neuroscience plc, Hodgkin Building, King\u2019s College, London SE1 1UL, UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022335418","display_name":"Sarah Rose","orcid":"https://orcid.org/0000-0003-4723-7665","observed_orcids":["https://orcid.org/0000-0003-4723-7665"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sarah Rose","raw_affiliation_strings":["NDRC, School of Biomedical and Health Sciences, King\u2019s College, London SE1 1UL, UK","Proximagen Neuroscience plc, Hodgkin Building, King\u2019s College, London SE1 1UL, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NDRC, School of Biomedical and Health Sciences, King\u2019s College, London SE1 1UL, UK","institution_ids":["https://openalex.org/I183935753"]},{"raw_affiliation_string":"Proximagen Neuroscience plc, Hodgkin Building, King\u2019s College, London SE1 1UL, UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037968910","display_name":"Mark Jairaj","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mark Jairaj","raw_affiliation_strings":["Proximagen Neuroscience plc, Hodgkin Building, King\u2019s College, London SE1 1UL, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Proximagen Neuroscience plc, Hodgkin Building, King\u2019s College, London SE1 1UL, UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088010523","display_name":"Kayhan A. Tayarani\u2010Binazir","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Kayhan A. Tayarani-Binazir","raw_affiliation_strings":["Proximagen Neuroscience plc, Hodgkin Building, King\u2019s College, London SE1 1UL, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Proximagen Neuroscience plc, Hodgkin Building, King\u2019s College, London SE1 1UL, UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006057213","display_name":"Alexander Syme","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Alexander Syme","raw_affiliation_strings":["Proximagen Neuroscience plc, Hodgkin Building, King\u2019s College, London SE1 1UL, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Proximagen Neuroscience plc, Hodgkin Building, King\u2019s College, London SE1 1UL, UK","institution_ids":["https://openalex.org/I183935753"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5085359308"],"corresponding_institution_ids":["https://openalex.org/I75059550"],"apc_list":{"value":3880,"currency":"USD","value_usd":3880},"apc_paid":null,"fwci":0.7791,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":{"value":0.72344307,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"23","issue":"19","first_page":"5279","last_page":"5282"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9854000210762024,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9854000210762024,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.004100000020116568,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dipeptide-derivatives","display_name":"dipeptide derivatives","score":0.8600000143051147},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.9909999966621399},{"id":"https://openalex.org/keywords/6-ohda-lesion","display_name":"6-hydroxydopamine lesion","score":0.9580000042915344},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.6430000066757202},{"id":"https://openalex.org/keywords/auc","display_name":"AUC","score":0.46399998664855957},{"id":"https://openalex.org/keywords/peptide-synthesis","display_name":"peptide synthesis","score":0.49799999594688416}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9129519462585449},{"id":"https://openalex.org/C2779138802","wikidata":"https://www.wikidata.org/wiki/Q418602","display_name":"Dipeptide","level":3,"score":0.8846777677536011},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.6076697707176208},{"id":"https://openalex.org/C104264131","wikidata":"https://www.wikidata.org/wiki/Q898637","display_name":"Isopropyl","level":2,"score":0.5862163305282593},{"id":"https://openalex.org/C114373084","wikidata":"https://www.wikidata.org/wiki/Q273499","display_name":"Chemical synthesis","level":3,"score":0.5646771192550659},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.5296986699104309},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5288054943084717},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.49999308586120605},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.4313175082206726},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.41847851872444153},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.41141220927238464},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3905739188194275},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2829471230506897},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.16650566458702087},{"id":"https://openalex.org/C155647269","wikidata":"https://www.wikidata.org/wiki/Q243455","display_name":"Medicinal chemistry","level":1,"score":0.1526610255241394},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.10343074798583984},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000978","descriptor_name":"Antiparkinson Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000978","descriptor_name":"Antiparkinson Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D000978","descriptor_name":"Antiparkinson Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004151","descriptor_name":"Dipeptides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004151","descriptor_name":"Dipeptides","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D004151","descriptor_name":"Dipeptides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007980","descriptor_name":"Levodopa","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007980","descriptor_name":"Levodopa","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D007980","descriptor_name":"Levodopa","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D007980","descriptor_name":"Levodopa","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009043","descriptor_name":"Motor Activity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.bmcl.2013.08.007","doi":"https://doi.org/10.1016/j.bmcl.2013.08.007","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2013.08.007","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},{"id":"pmid:23973169","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23973169","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & medicinal chemistry letters","raw_type":"Journal Article"},{"id":"pmh:oai:kclpure.kcl.ac.uk:publications/9c258cad-d5ff-4b61-8288-70ea53551c2a","doi":null,"is_oa":false,"landing_page_url":"https://kclpure.kcl.ac.uk/portal/en/publications/9c258cad-d5ff-4b61-8288-70ea53551c2a","pdf_url":null,"source":{"id":"https://openalex.org/S4306400216","display_name":"Research Portal (King's College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I183935753","host_organization_name":"King's College London","host_organization_lineage":["https://openalex.org/I183935753"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Zhou, T, Hider, R C, Jenner, P, Campbell, B, Hobbs, C J, Rose, S, Jairaj, M, Tayarani-Binazir, K A & Syme, A 2013, 'Design, synthesis and biological evaluation of peptide derivatives of L-dopa as anti-parkinsonian agents', BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS, vol. 23, no. 19, N/A, pp. 5279-5282. https://doi.org/10.1016/j.bmcl.2013.08.007","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8560000061988831,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W1987043824","https://openalex.org/W1994137137","https://openalex.org/W1994504209","https://openalex.org/W1995163833","https://openalex.org/W2014090385","https://openalex.org/W2027274005","https://openalex.org/W2040890619","https://openalex.org/W2048418563","https://openalex.org/W2056798863","https://openalex.org/W2057223343","https://openalex.org/W2073161317","https://openalex.org/W2086483799","https://openalex.org/W2108024088","https://openalex.org/W2126005891","https://openalex.org/W2128890618","https://openalex.org/W2133230336","https://openalex.org/W2145954079","https://openalex.org/W2331956936","https://openalex.org/W2949440831","https://openalex.org/W4242292959","https://openalex.org/W4243009512","https://openalex.org/W4248107770"],"related_works":["https://openalex.org/W4242292959","https://openalex.org/W1987043824","https://openalex.org/W2301593059","https://openalex.org/W2951950574","https://openalex.org/W2010497225","https://openalex.org/W3133965166","https://openalex.org/W2002481554","https://openalex.org/W1153323662","https://openalex.org/W2605629365","https://openalex.org/W2022451163"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}